Your Article Summary
See Latest ArticlesTreatment Modalities for Graves' Ophthalmopathy - Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 06/15/09
Stiebel-Kalish H et al. - Current evidence demonstrates the efficacy of intravenous corticosteroids in decreasing CAS in patients with moderate-to-severe GO. Intravenous pulse corticosteroids therapy has a small but statistically significant advantage oral therapy, and causes significantly less adverse events. Somatostatin analogs have marginal clinical efficacy. The efficacy of orbital radiotherapy as single therapy remains unclear, while the combination of radiotherapy with corticosteroids has better efficacy than either radiotherapy or oral costicosteroids alone.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09
Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09
Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09
Today in Neuro-Ophthalmology...keeping you current
Receive free subspecialty "5-minute updates" via email
A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves orbitopathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/02/09
Infliximab and anterior optic neuropathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/23/09
Rituximab in the Treatment of Thyroid Eye Disease: Science Fiction
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09